1112 Central GLP-1/GLP-1R Resistance Mediates Enteral Feeding Intolerance in Patients With Traumatic Brain Injury
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: Central GLP-1/GLP-R system plays a crucial role in energy metabolism by modulating feeding-related neuropeptides in hypothalamus, delaying gastric emptying, and reducing nutrient intake. We hypothesized that feeding intolerance in TBI patients is caused by GLP-1 resistance, which attributed to interruption of central GLP-1/GLP-1R signaling. METHODS: A prospective enteral feeding was conducted in patients with TBI (n = 109) with the target of 25kcal/kg·d and adjusted according to the tolerance status. The blood samples were collected at post-injury days 1–3 (PID1), 4–7 (PID2), 8–10 (PID3), and 11–14 (PID4). The plasma levels of GLP-1, insulin, glucose, GFAP and the biomarkers of intestinal mucosal barrier during the first 14 days were kinetically observed. RESULTS: Although insulin and glucose levels were comparable between the two groups, plasma GLP-1 level was significantly elevated in the intolerance group relative to the well tolerance group (p = 0.024). The elevation of GLP-1 was particularly prominent in patients with critical TBI (GCS 3-5) (p < 0.001). Partial correlation analysis demonstrated a consistent correlation between GFAP and GLP-1 (r = 0.259, p < 0.001). In patients without exogenous insulin therapy (n = 59), the insulin level in the intolerance group was significantly higher than that in the well tolerance group (p = 0.022). Unexpectedly, the biomarkers of intestinal mucosal barrier were comparable between the two groups. The GLP-1 level at PID3 (p = 0.001) and insulin level at PID1 (p = 0.006) were independently associated with feeding intolerance. CONCLUSIONS: The persistent elevated plasma GLP-1 levels other than the biomarkers of intestinal mucosal barrier in feeding intolerance relative to tolerance patients indicated a central driven mechanism underlying the enteral intolerance in patients with TBI. The GLP-1 based enteral feeding strategy may be used for personalized feeding monitoring in patients with TBI.
Fields of Study & Subjects
Clinical Nutrition and Gastroenterology
Regulation of Appetite and Obesity
Hyperglycemia and glycemic control in critically ill and hospitalized patients
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 209–209
- Publication date
- 26 March 2026
- Language
- EN